<aside> 📺

Watch this 8 min video chapter on how to easily mine in a few minutes all recent scientific literature to find established and emerging targets with the level of validation and much more.

https://share.descript.com/view/Tec5VnCq7Fo?t=3669.517

</aside>

<aside> 1️⃣

Query in Publications - Search By: Title & Abstract

<aside> 🔎

"Atopic dermatitis" target

</aside>

</aside>

<aside> 2️⃣

Filter:

• Publication year: 2025

Sort:

• Journal Ranking </aside>

<aside> 3️⃣

AI - Ask question to first 50 results:

<aside> ❓

What are emerging new targets for Atopic Dermatitis and what's the validation so far?

</aside>

• AI Answer (click to open) </aside>

<aside> 4️⃣

Filter:

• Publication year: 2024-2025: </aside>

<aside> 5️⃣

AI - One-by-one analysis

<aside> ❓

I want to identify for Atopic Dermatitis validated, emerging and novel targets for Atopic Dermatitis with clarity on their validation, understanding of the biology, context, assets in development, MOA, companies involved, etc.

</aside>

</aside>

<aside> 6️⃣

Analysis: in Excel, filter on novelty type etc.

<aside> ➡️

Access the Excel file analysis here:

Finding novel validated targets for Atopic Dermatitis.xlsx

</aside>

</aside>

<aside> 7️⃣

ChatGPT: upload file and ask:

<aside> ❓

I am uploading a sheet with 1600 publications (in rows from row 33 onwards with column headers in row 32) on Atopic Dermatitis. The first 20 columns try to answer questions related to our goal of finding validated, emerging and novel targets with clarity on their validation, understanding of the biology, context, assets in development, MOA, companies involved, etc.

I want you to:

• summarize established vs emerging targets for AD
• identify novel emerging targets for Atopic Dermatitis we should explore.
• list which ones have validation in preclinical or early clinical phases with context on the validation
• a shortlist of targets we should explore experimentally

</aside>

<aside> ➡️

Access the chat here: https://chatgpt.com/share/695f87af-0e44-800a-a52a-4a8166e1327c

</aside>

</aside>